Live attenuated HIV vaccines: A proposal for further research and development

AIDS Research and Human Retroviruses

Volumn 16, Issue 15, 2000, Pages 1453-1461

  Mills, J ^a   Desrosiers, R ^b   Rud, E ^c   Almond, N ^d  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HEALTH CANADA   (Canada)

^d NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; VACCINE PRODUCTION; VIRUS LOAD;

AIDS VACCINES; ANIMALS; CONSUMER PRODUCT SAFETY; HIV INFECTIONS; HUMANS; RESEARCH; VACCINES, ATTENUATED;

EID: 0034633776     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200750005976     Document Type: Conference Paper

References (37)

1. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge
2. The business of science and the science of business in the quest for an AIDS vaccine
3. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
4. A naturally-attenuated SIVmac32H vaccine or viral interference?
5. Attenuated simian immunodeficiency virus protects macaques against challenge with virus-infected cells
6. Immunologic and virologic status after 14-18 years of infection with an attenuated strain of HIV-1 - A report from the Sydney Blood Bank Cohort
7. Genetic instability of live attenuated human immunodeficiency virus type 1 vaccine strains
8. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection
9. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection
10. Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates
11. Expression of interferon-γ by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques
12. Importance of the intracytoplasmic domain of the SIV envelope glycoprotein for pathogenesis
13. Features of the SIVmac transmembrane glycoprotein cytoplasmic domain that are important for Env functions
14. The intracytoplasmic domain of Env-TM is a locus for attenuation of simian immunodeficiency vires (SIVmac) in rhesus macaques
15. Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein
16. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: Inverse relationship of degree of protection with level of attenuation
17. Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-κB (I-κB-αS32/36A) and the implications for vaccine development
18. Replacement of post-transcriptional regulation in SIVmac239 generated a Rev-independent infectious virus able to propagate in rhesus peripheral blood mononuclear cells
19. Reduced viral load and lack of CD4 depletion in SCID-hu mice infected with Rev-independent clones of human immunodeficiency virus type 1
20. Persistent infection of rhesus macaques by the Rev-independent Nef(-) SIVmac239: Replication kinetics and genomic stability
21. Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1
22. Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS
23. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques
24. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence
25. Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion
26. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients
27. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA
28. Viremia and AIDS in rhesus macaques after intramuscular inoculation of plasmid DNA encoding full-length SIV-mac239
29. Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission
30. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
31. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
32. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo
33. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge
34. The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env
35. Simian immunodeficiency virus and human immunodeficiency virus type 1 Nef proteins show distinct patterns and mechanisms of Src kinase activation
36. Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections
37. Chimps and lethal strain [of HIV-1] a bad mix